noom glp 1 companion Noom's GLP-1 Receives Major Update to Prepare for New Expected Prescription Drug Use-Related Software (PDURS) Model Noom GLP-1rx Plus Program —

Truveta Research examines new sleep apnea, diabetes, and cardiovascular diagnoses after a first GLP-1 prescription.

Stanford Medicine psychiatrist Anna Lembke unpacks the potential of FDA-approved weight-reducing GLP-1 drugs like Ozempic as tools in treating addiction.

Researchers found that 32% of patients with eating disorders report having used a weight loss injection at least once.

doi:10.1001/jamanetworkopen.2024.57349

Accessing GLP-1 medications without insurance is achievable through compounded formulations, direct-to-consumer providers, and cost-effective protocols

Plasma concentration versus time profiles and pharmacokinetic parameters of semaglutide were predicted for humans by applying the average body weight